Gilead Sciences: About to start trials of an inhaled version of Remdesivir

Gilead Sciences CEO in a statement announced on Monday that the company is about to start trials of an inhaled version of its experimental coronavirus

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *